id string | trial_context string | compound string | dose_regimen string | baseline_state_summary string | early_signal_window string | biomarker_shift_summary string | cross_system_coupling_notes string | observed_short_term_effect string | adaptation_onset_time string | acute_response_pattern string | coupling_shift_signature string | stabilization_direction string | early_compensation_flag int64 | trajectory_seed_class string | confidence_score float64 | notes string | constraints string | gold_checklist string |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EAPD-001 | phase1 healthy | compound-A | single low dose | stable metabolic baseline | 0-24h | glucose down; insulin up mild | liver-muscle coupling intact | mild metabolic shift | t=6h | smooth_adjustment | tightened metabolic coupling | toward_new_stable | 0 | durable_seed | 0.78 | clean adaptation | Under 220 words | onset+pattern+coupling+direction+flag+class+confidence |
EAPD-002 | phase1 patient | compound-B | daily x3 | inflamed baseline | 0-48h | cytokine drop then rebound | immune-liver coupling oscillates | initial symptom relief | t=10h | oscillatory | immune rebound loop | unstable | 1 | compensatory_seed | 0.71 | early rebound | Under 220 words | onset+pattern+coupling+direction+flag+class+confidence |
EAPD-003 | phase1 healthy | compound-C | single high | normal baseline | 0-12h | HR up; cortisol spike | cardio-endocrine decouple | agitation | t=2h | stress_response | decoupled cardio-endocrine | destabilizing | 1 | destabilizing_seed | 0.82 | rapid stress | Under 220 words | onset+pattern+coupling+direction+flag+class+confidence |
EAPD-004 | phase1 patient | compound-D | daily low | fatigue baseline | 0-72h | ATP markers rise steady | mito-neuro coupling improves | energy gain | t=18h | gradual_alignment | mitochondrial coherence rise | toward_new_stable | 0 | durable_seed | 0.75 | positive adaptation | Under 220 words | onset+pattern+coupling+direction+flag+class+confidence |
EAPD-005 | phase1 healthy | compound-E | single dose | normal baseline | 0-24h | dopamine spike then normalize | neuro-endocrine stable | mild alertness | t=4h | transient_adjustment | short coupling fluctuation | returns_baseline | 0 | neutral_seed | 0.69 | neutral | Under 220 words | onset+pattern+coupling+direction+flag+class+confidence |
EAPD-006 | phase1 patient | compound-F | daily | autoimmune baseline | 0-48h | inflammation down then drift | immune-metabolic drift | partial relief | t=12h | partial_adjustment | metabolic strain rising | fragile | 1 | oscillatory_seed | 0.73 | fragile stabilization | Under 220 words | onset+pattern+coupling+direction+flag+class+confidence |
What this dataset tests
Whether a system can detect the earliest systemic adaptation to a drug.
It evaluates how the human system begins to stabilize, compensate, or destabilize.
Required outputs
- adaptation_onset_time
- acute_response_pattern
- coupling_shift_signature
- stabilization_direction
- early_compensation_flag
- trajectory_seed_class
- confidence_score
Use case
Early-phase trial interpretation.
Predict long-term tolerance or durability from short-term data.
Identify drugs that induce coherent stabilization vs compensation.
- Downloads last month
- 16